Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print October 1, 2008, doi:10.1212/01.wnl.0000319696.14225.67)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
01.wnl.0000319696.14225.67v1
71/21/1660    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houlden, H.
Right arrow Articles by Reilly, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houlden, H.
Right arrow Articles by Reilly, M. M.
Related Collections
Right arrowRelated Article
Received October 24, 2007
Accepted April 24, 2008

Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2

H. Houlden MD*, M. Laura MD, F. Wavrant–De Vrièze PhD, J. Blake MD, N. Wood MD, and M. M. Reilly MD

From the Department of Molecular Neurosciences (H.H., M.L., N.W., M.M.R.), and Center for Neuromuscular Disease (H.H., M.L., J.B., N.W., M.M.R.), Institute of Neurology and The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; Laboratory of Neurogenetics (F.W.-D.V.), National Institute on Aging, National Institutes of Health, Bethesda, MD; and Department of Clinical Neurophysiology (J.B.), Norfolk and Norwich University Hospital, Norwich, Norfolk, UK.


* To whom correspondence should be addressed. E-mail: h.houlden{at}ion.ucl.ac.uk.

Background: Charcot-Marie-Tooth disease (CMT) is the most common inherited neuromuscular disorder and is characterized by significant clinical and genetic heterogeneity. Recently, mutations in both the small heat shock protein 27 (HSP27 or HSPB1) and 22 (HSP22 or HSPB8) genes have been reported to cause autosomal dominant CMT with minimal sensory involvement (CMT 2F/CMT2L) and autosomal dominant distal hereditary motor neuropathy type II (dHMN II).

Methods: We analyzed the HSPB1 and HSPB8 genes in a large clinically well-characterized series of dHMN and CMT type 2 (CMT2) cases and families using linkage analysis and direct sequencing of these genes.

Results: We identified a novel homozygous mutation in the {alpha}-crystallin domain of HSPB1 segregating in an autosomal recessive fashion in a family with distal HMN/CMT2. A further four heterozygous HSPB1 mutations were identified in four autosomal dominant families dHMN/CMT2, and two sporadic cases were identified with probable de novo mutations. In the autosomal dominant and autosomal recessive families, there were no clinical sensory findings, but reduced sural nerve action potential amplitudes were found in some affected individuals, indicating that long sensory axons are mildly affected in this predominantly motor disorder.

Conclusions: This extends the clinical and electrophysiologic spectrum of HSPB1 mutations and identifies four unreported dominant HSPB1 mutations and the first family where the HSPB1 mutation acts in a recessive way to cause distal HMN.


Related Article

Hereditary motor neuropathy and heat shock proteins: A shocking transformation
Clifton Gooch and Michael Shy
Neurology 2008 71: 1656-1657. [Full Text] [PDF]



This article has been cited by other articles:


Home page
NeurologyHome page
C. Gooch and M. Shy
Hereditary motor neuropathy and heat shock proteins: A shocking transformation
Neurology, November 18, 2008; 71(21): 1656 - 1657.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by AAN Enterprises, Inc.